Related Experiment Video

Updated: May 22, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Vaccines for enteric diseases: a meeting summary

Duncan Steele1, Mark Riddle, Lillian van de Verg

  • 1Rotavirus Vaccine Program, PATH, Seattle, WA, USA. duncan.steele@gatesfoundation.org

Expert Review of Vaccines
|May 4, 2012
PubMed

Insights

The 6th Vaccines for Enteric Diseases Symposium highlighted progress in developing vaccines against infectious diarrhea, a major global child health threat. New vaccine trials and implementation updates for rotavirus, cholera, and typhoid were presented.

Area of Science:

  • Vaccinology
  • Infectious Diseases
  • Global Public Health

Background:

  • Infectious diarrhea causes significant mortality and morbidity, especially in developing nations' young children.
  • Diarrheal illnesses contribute to millions of deaths in children under five, exceeding malaria, HIV/AIDS, and tuberculosis combined.
  • The 6th Vaccines for Enteric Diseases Symposium convened global experts to address this critical health issue.

Framework:

  • The symposium focused on advancements in vaccine development for enteric pathogens.
  • Discussions covered early clinical trials for enterotoxigenic Escherichia coli, Shigella, noroviruses, and conjugate typhoid vaccines.
  • Progress in implementing existing vaccines like rotavirus, cholera, and typhoid was also a key theme.

Implementation:

  • Updates were provided on the global rollout and impact of rotavirus vaccines.
  • Strategies for implementing cholera vaccines in endemic regions were discussed.
  • The deployment of typhoid conjugate vaccines was reviewed, focusing on public health benefits.

Implications:

  • Successful vaccine development and implementation can drastically reduce childhood mortality from diarrheal diseases.
  • Continued research and collaboration are crucial for combating enteric infections worldwide.
  • The symposium underscored the potential of vaccinology to significantly improve child survival rates in vulnerable populations.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...